High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Past Returns: Outperforming stock! In past three years, the stock has provided 34.1% return compared to 7.9% by NIFTY 50.
Profitability: Recent profitability of 14% is a good sign.
Technicals: Bullish SharesGuru indicator.
Size: It is among the top 200 market size companies of india.
Balance Sheet: Reasonably good balance sheet.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Growth: Awesome revenue growth! Revenue grew 32.7% over last year and 57.9% in last three years on TTM basis.
Insider Trading: Significant insider selling noticed recently.
Dilution: Company has a tendency to dilute it's stock investors.
Momentum: Stock has a weak negative price momentum.
Valuation | |
|---|---|
| Market Cap | 1.87 LCr |
| Price/Earnings (Trailing) | 78.66 |
| Price/Sales (Trailing) | 11.96 |
| EV/EBITDA | 40.1 |
| Price/Free Cashflow | 79.84 |
| MarketCap/EBT | 65.33 |
| Enterprise Value | 2.01 LCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 15.65 kCr |
| Rev. Growth (Yr) | 56.3% |
| Earnings (TTM) | 2.16 kCr |
| Earnings Growth (Yr) | 3.3% |
Profitability | |
|---|---|
| Operating Margin | 19% |
| EBT Margin | 18% |
| Return on Equity | 12.26% |
| Return on Assets | 4.87% |
| Free Cashflow Yield | 1.25% |
Growth & Returns | |
|---|---|
| Price Change 1W | -3.9% |
| Price Change 1M | 1.2% |
| Price Change 6M | 25% |
| Price Change 1Y | 36.9% |
| 3Y Cumulative Return | 34.1% |
| 5Y Cumulative Return | 26.3% |
| 7Y Cumulative Return | 28.8% |
| 10Y Cumulative Return | 20.7% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -12.71 kCr |
| Cash Flow from Operations (TTM) | 3.02 kCr |
| Cash Flow from Financing (TTM) | 10.15 kCr |
| Cash & Equivalents | 1.12 kCr |
| Free Cash Flow (TTM) | 2.35 kCr |
| Free Cash Flow/Share (TTM) | 61.68 |
Balance Sheet | |
|---|---|
| Total Assets | 44.31 kCr |
| Total Liabilities | 26.73 kCr |
| Shareholder Equity | 17.59 kCr |
| Current Assets | 9.39 kCr |
| Current Liabilities | 8.34 kCr |
| Net PPE | 4.91 kCr |
| Inventory | 3.14 kCr |
| Goodwill | 3.99 kCr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.33 |
| Debt/Equity | 0.84 |
| Interest Coverage | 3.52 |
| Interest/Cashflow Ops | 5.77 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 38 |
| Dividend Yield | 0.77% |
| Shares Dilution (1Y) | 12.4% |
| Shares Dilution (3Y) | 12.4% |
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Past Returns: Outperforming stock! In past three years, the stock has provided 34.1% return compared to 7.9% by NIFTY 50.
Profitability: Recent profitability of 14% is a good sign.
Technicals: Bullish SharesGuru indicator.
Size: It is among the top 200 market size companies of india.
Balance Sheet: Reasonably good balance sheet.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Growth: Awesome revenue growth! Revenue grew 32.7% over last year and 57.9% in last three years on TTM basis.
Insider Trading: Significant insider selling noticed recently.
Dilution: Company has a tendency to dilute it's stock investors.
Momentum: Stock has a weak negative price momentum.
Investor Care | |
|---|---|
| Dividend Yield | 0.77% |
| Dividend/Share (TTM) | 38 |
| Shares Dilution (1Y) | 12.4% |
| Earnings/Share (TTM) | 62.6 |
Financial Health | |
|---|---|
| Current Ratio | 1.13 |
| Debt/Equity | 0.84 |
Technical Indicators | |
|---|---|
| RSI (14d) | 45.11 |
| RSI (5d) | 0.00 |
| RSI (21d) | 50.89 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Buy |
| RSI21 Signal | Hold |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Buy |
| SMA 100 Signal | Buy |
Summary of Torrent Pharmaceuticals's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Understand Torrent Pharmaceuticals ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| TORRENT INVESTMENTS LIMITED (FORMERLY KNOWN AS TORRENT INVESTMENTS PRIVATE LIMITED) | 60.78% |
| NPS TRUST | 2.23% |
| AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND A/C | 1.28% |
| KOTAK CONTRA FUND | 1.18% |
| HDFC MUTUAL FUND - HDFC INNOVATION FUND | 1.03% |
| Torrent Urja 39 Private Limited | 0% |
| Torrent Urja 40 Private Limited | 0% |
| Torrent Urja 41 Private Limited | 0% |
| Torrent Urja 42 Private Limited | 0% |
| Torrent Urja 43 Private Limited | 0% |
| Torrent Urja 44 Private Limited | 0% |
| Torrent Urja 45 Private Limited | 0% |
| Torrent Urja 46 Private Limited | 0% |
| Torrent Urja 47 Private Limited | 0% |
| Dwarka Renewables Private Limited | 0% |
| Azadirachta Indica Renewables Private Limited | 0% |
| Onix-One Enersol Private Limited | 0% |
| Torrent Gas Chennai Private Limited | 0% |
| Torrent Gas Jaipur Private Limited | 0% |
| Dholpur CGD Private Limited | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Torrent Pharmaceuticals against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries | 4.67 LCr | 62.14 kCr | +3.00% | +21.70% | 38.59 | 7.51 | - | - |
| CIPLA | Cipla | 1.18 LCr | 29.16 kCr | +2.20% | -1.80% | 35.07 | 4.06 | - | - |
| LUPIN | Lupin | 1.08 LCr | 30.44 kCr | -3.90% | +21.60% | 19.53 | 3.55 | - | - |
| DRREDDY | Dr. Reddy's Lab | 97.82 kCr | 34.65 kCr | -13.10% | -2.40% | 30.29 | 2.82 | - | - |
| AUROPHARMA | Aurobindo Pharma | 95.4 kCr | 35.62 kCr | +6.50% | +55.00% | 25.91 | 2.68 | - | - |
Comprehensive comparison against sector averages
TORNTPHARM metrics compared to Pharmaceuticals
| Category | TORNTPHARM | Pharmaceuticals |
|---|---|---|
| PE | 78.66 | 39.15 |
| PS | 11.96 | 5.34 |
| Growth | 32.7 % | 11.6 % |
Torrent Pharmaceuticals is a prominent pharmaceuticals company with the stock ticker TORNTPHARM and a significant market capitalization of Rs. 112,871.4 Crores. Founded in 1959 and based in Ahmedabad, India, the company was previously known as Trinity Laboratories before changing its name in 1971.
The company specializes in the research, development, manufacturing, and marketing of generic pharmaceutical formulations. Its operations span across multiple countries, including India, the United States, Brazil, Germany, and other international markets.
Torrent Pharmaceuticals offers a wide range of products across various therapeutic areas such as:
Additionally, the company provides contract manufacturing services.
With a trailing twelve-month revenue of Rs. 11,374 Crores, Torrent Pharmaceuticals has demonstrated strong profitability, achieving a profit of Rs. 1,862 Crores over the past year. The company has experienced a revenue growth of 33.9% over the last three years.
Investors benefit from its commitment to returning value, as Torrent Pharmaceuticals distributes dividends with a yield of 1.62% per year. In the previous 12 months, the company returned a dividend of Rs. 54 per share. Torrent Pharmaceuticals is a subsidiary of Torrent Investments Private Limited.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
TORNTPHARM vs Pharmaceuticals (2021 - 2026)